Evidence map›Paper›PMID 35409727›Full record

ArticleInternational journal of environmental research and public health2022

The Seroprevalence of SARS-CoV-2 Antibodies among HealthCare Workers in University Hospital in Krakow before the Era of Vaccination.

Barbara Żółtowska, Ilona Barańska, Estera Jachowicz, Wojciech Sydor, Barbara Maziarz, Krzysztof Mydel, Anna Różańska, Barbara Wizner, Jerzy Rosiński, Magdalena Kossowska and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Barbara ŻółtowskaCenter for Innovative Therapy, Clinical Research Coordination Center, University Hospital in Krakow, 30-688 Krakow, Poland.ORCID 0000-0002-1771-4558
Ilona BarańskaLaboratory for Research on Aging Society, Department of Sociology of Medicine, Chair of Epidemiology and Preventive Medicine, Medical Faculty, Jagiellonian University Medical College, 31-034 Krakow, Poland.
Estera JachowiczChair of Microbiology, Medical Faculty, Jagiellonian University Medical College, 31-121 Krakow, Poland.
Wojciech SydorCenter for Innovative Therapy, Clinical Research Coordination Center, University Hospital in Krakow, 30-688 Krakow, Poland.
Barbara MaziarzDepartment of Clinical Biochemistry, Jagiellonian University Medical College, 31-066 Krakow, Poland.
Krzysztof MydelDeputy Director for Coordination and Development, University Hospital in Krakow, 30-688 Krakow, Poland.
Anna RóżańskaChair of Microbiology, Medical Faculty, Jagiellonian University Medical College, 31-121 Krakow, Poland.
Barbara WiznerDepartment of Internal Medicine and Gerontology, Jagiellonian University Medical College, 30-688 Krakow, Poland.
Jerzy RosińskiFaculty of Management and Social Communication, The Institute of Economics, Finance and Management, Jagiellonian University, 30-348 Krakow, Poland.ORCID 0000-0002-8348-2839
Magdalena KossowskaFaculty of Management and Social Communication, The Institute of Economics, Finance and Management, Jagiellonian University, 30-348 Krakow, Poland.
Kaja GłombFaculty of Management and Social Communication, The Institute of Applied Psychology, Jagiellonian University, 30-348 Krakow, Poland.
Jadwiga Wójkowska-MachChair of Microbiology, Medical Faculty, Jagiellonian University Medical College, 31-121 Krakow, Poland.ORCID 0000-0003-0756-1639
Jagiellonian University · PLKrakow Cardiovascular Research Institute · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKnowledge of occupational health is crucial to the safety of healthcare workers in the pandemic period. The aim of our study was the rating of SARS-CoV-2 seroprevalence in connection with selected demographic, social, and organizational factors, as well as the identification of key elements determining the safety of HCWs and patients of the University Hospital in Krakow.

methodsThis was a non-interventional, uncontrolled, open, single-center, cross-sectional online survey on the preparedness for the COVID-19 epidemic and the seroprevalence of medical and non-medical HCWs and students. Serum specimens from 1221 persons were tested using an immunoassay analyzer based on the ECLIA technique for the anti-SARS-CoV-2 antibodies IgM + IgG.

resultsThe total seroprevalence was 42.7%. In medical students it was 25.2%, while in physicians it was 43.4% and in nurses/midwives it was 48.1%. Of those who tested positive, 21.5% did not know their serological status. The use of personal protective equipment did not have any significant impact on the result of testing for anti-SARS-CoV-2 antibodies. The risk of developing the disease was not influenced by sex, professional work experience, workplace, or intensity of contact with the patient. Among the studied elements, only care of COVID-19 patients significantly increased the risk. The protective factor was starting work between the waves of the epidemic (June-September 2020).

conclusionsPPE is only one element of infection prevention and control-without other components, such as hand hygiene, it can be dangerous and contribute to self-infection. It is also very important to test healthcare workers. Not being aware of the COVID-19 status of HCWs poses a threat to other staff members, as well as patients and the family and friends of the infected. Thus, extreme caution should be applied when employing respirators with exhalation valves during the COVID-19 pandemic.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralCross-Sectional StudiesHealth PersonnelHospitals, UniversityHumansImmunoglobulin GPandemicsSeroepidemiologic StudiesVaccinationAntibodies, ViralImmunoglobulin GCOVID-19healthcare workersinfection prevention and control practicesseroprevalencework culture

Identifiers

PMID35409727
PMCPMC8997762
OpenAlexW4220811486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.